APA ציטוט

Nölting, S., Rentsch, J., Freitag, H., Detjen, K., Briest, F., Möbs, M., . . . Grabowski, P. (2017). The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models. PLoS One.

Citação norma Chicago

Nölting, Svenja, et al. "The Selective PI3Kα Inhibitor BYL719 As a Novel Therapeutic Option for Neuroendocrine Tumors: Results From Multiple Cell Line Models." PLoS One 2017.

ציטוט MLA

Nölting, Svenja, et al. "The Selective PI3Kα Inhibitor BYL719 As a Novel Therapeutic Option for Neuroendocrine Tumors: Results From Multiple Cell Line Models." PLoS One 2017.